Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
SNOAW was delisted on the 22nd of January, 2020.
3 hedge funds and large institutions have $9K invested in Sonoma Pharmaceuticals, Inc. Warrants in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
350% more capital invested
Capital invested by funds: $2K → $9K (+$7K)
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$5.66K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$97 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $6K | +$5.66K | +14,811 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$97 | +255 | +7% |
|
3
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
SNOAW Hedge Fund Activity: Q4 2017 in Review
3 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q4 2017, worth a combined $9K — up 350% from $2K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SNOAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $5.66K.
- 3 institutional investors held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q4 2017, up from 2 in Q3 2017.
- Funds reported $9K of Sonoma Pharmaceuticals, Inc. Warrants stock for Q4 2017, up 350% quarter-over-quarter.
- 1 fund opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q4 2017 and 0 closed out, a net change of +1 holder.
- The largest Sonoma Pharmaceuticals, Inc. Warrants buyer in Q4 2017 was Virtu Financial, an estimated $5.66K added.
Based on aggregated 13F filings for Q4 2017.